시장보고서
상품코드
1184203

세계의 CRISPR 기술 시장

CRISPR Technology: Global Markets

발행일: | 리서치사: BCC Research | 페이지 정보: 영문 131 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 CRISPR 기술 시장 규모는 2022년 33억 달러에서 2027년에는 92억 달러로 성장하고, 2022-2027년간 CAGR은 22.3%로 예측됩니다.

바이오테크놀러지 및 제약 기업 부문은 2022년 26억 달러에서 2027년에는 73억 달러로 성장하고, 2022-2027년간 CAGR은 22.1%로 예측됩니다. 또한 학술·정부 연구기관 부문은 2022년 3억 7,160만 달러에서 2027년에는 10억 달러로 성장하고, CAGR은 23.5%로 예측됩니다.

세계의 CRISPR 기술(CRISPR Technology) 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모 추정과 예측, 각종 부문·지역/주요 국가별 상세 분석, 경쟁 환경, 주요 기업 개요 등을 정리했습니다.

목차

제1장 서론

제2장 요약과 하이라이트

제3장 시장 개요

  • CRISPR : 유전자 편집
  • CRISPR-Cas 시스템의 컴포넌트
    • SgRNA
    • Cas9 뉴클레아제
  • CRISPR-Cas의 구조
  • CRISPR-Cas9 시스템의 이점
  • CRISPR 게놈 편집의 인기
  • 유전자 편집의 장점
  • CRISPR 개발 단계
  • 시장 가능성
  • 규제 체계
  • Porter's Five Forces 분석
  • 과학 출판물
  • 특허 분석
  • CRISPR의 미래
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 과제

제4장 산업 구조

  • 커머셜 테라퓨틱스
  • 유전적 에러 수정
  • 미생물
  • 더 건강한 식품

제5장 CRISPR 기술 시장에 대한 COVID-19의 영향

제6장 경쟁 상황

  • 개요
  • 경쟁 시나리오
  • Beam Therapeutics
  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • 성장 전략

제7장 세계의 CRISPR 기술 시장 : 최종사용자별

  • 시장 개요
  • 시장 점유율과 예측
  • 바이오테크놀러지·제약회사
  • 학술 연구기관·정부 연구기관
  • 수탁연구기관

제8장 세계의 CRISPR 기술 시장 : 용도별

  • 시장 점유율과 예측
  • 의약품 개발
  • 농업
  • 진단
    • 감염증
    • 비감염증
  • 임상 요법
  • 기타

제9장 세계의 CRISPR 기술 시장 : 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제10장 기업 개요

  • CARIBOU BIOSCIENCES
  • CRISPR THERAPEUTICS AG
  • DANAHER CORP.
  • EDITAS MEDICINE
  • GENSCRIPT
  • HERA BIOLABS
  • INTELLIA THERAPEUTICS INC.
  • LONZA GROUP LTD.
  • MAMMOTH BIOSCIENCES INC.
  • NEW ENGLAND BIOLABS INC.
  • ORIGENE TECHNOLOGIES
  • PERKINELMER
  • PRECISION BIOSCIENCES
  • SYNTHEGO
  • THERMO FISHER SCIENTIFIC
  • TOOLGEN INC.
KSM 23.01.25

Highlights:

The global CRISPR Technology market reached $3.3 billion in 2022 and should reach $9.2 billion by 2027, with a compound annual growth rate (CAGR) of 22.3% during the forecast period of 2022-2027.

Biotechnology and pharmaceutical companies segment of the global CRISPR Technology market reached $2.6 billion in 2022 and should reach $7.3 billion by 2027, with a CAGR of 22.1% during the forecast period of 2022-2027.

Academics and government research institutes segment of the global CRISPR Technology market reached $371.6 million in 2022 and should reach $1 billion by 2027, with a CAGR of 23.5% during the forecast period of 2022-2027.

Report Scope:

The current report provides detailed exposure to the CRISPR technology market. This report highlights the current and future market potential of CRISPR technology, along with a detailed analysis of the drivers, restraints, and challenges in the market. The report also covers market projections for 2027, as well as the competitive environment and regulatory scenario. The report details the market share of CRISPR technology on applications and end users. The market is segmented into Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, and Contract Research Organizations (CROs) based on end users. The market is categorized as Drug Development, Agriculture, Diagnostics, Clinical therapy, and Others based on Application. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments. The report also discusses the impact of the COVID-19 pandemic on this market.

By geography, the market has been segregated into North America, Europe, Asia-Pacific, and the Rest of the world. The North American region includes countries such as the U.S. and Canada; Europe includes Germany, U.K., France, and the Rest of Europe; Asia-Pacific includes China, India, Japan, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2019 as the historic year, 2021 as the base year, and forecast for 2027.

Report Includes:

  • 17 data tables and 37 additional tables
  • An up-to-date overview and analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
  • Analyses of the global market trends, with historic revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for CRISPR technology, industry growth drivers, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and revenue forecast for the global CRISPR technology market in USD million terms, and corresponding market share analysis by application, end user, and region
  • Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and macroeconomic factors affecting the demand for CRISPR technology market over the coming years (2022-2027)
  • Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
  • A look at the recent technical breakthrough on the use of CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
  • Comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
  • Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
  • Insight into recent industry structure for CRISPR-Cas9 genome editing technology, competitive environment, clinical trials, ongoing research activities, and the COVID-19 impact on the marketplace
  • Company profiles of major players within the industry, including CRISPR Therapeutics AG, GenScript, Lonza Group Ltd, PerkinElmer and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

  • 1.1 Study Goals and Objectives
  • 1.2 Reasons for Doing This Study
  • 1.3 Intended Audience
  • 1.4 Scope of Report
  • 1.5 What's New in this Report?
  • 1.6 Information Sources
  • 1.7 Methodology
  • 1.8 Geographic Breakdown
  • 1.9 Analyst's Credentials
  • 1.10 BCC Custom Research
  • 1.11 Related BCC Research Reports

Chapter 2 Summary and Highlights

  • 2.1 Highlights of the Market for CRISPR Technology

Chapter 3 Market Overview

  • 3.1 CRISPR: Genetic Editing
  • 3.2 Components of CRISPR-Cas Systems
    • 3.2.1 SgRNA
    • 3.2.2 Cas9 Nucleases
  • 3.3 How CRISPR-Cas Works?
  • 3.4 Advantage of the CRISPR-Cas9 System
  • 3.5 Popularity of CRISPR Genome Editing
  • 3.6 Pros of Genetic Editing
  • 3.7 CRISPR Development Phases
    • 3.7.1 Discovery of CRISPR
    • 3.7.2 Discovery of Cas9 and PAM
    • 3.7.3 Hypothesis: Adaptive Immunity
    • 3.7.4 Adaptive Immunity
    • 3.7.5 Spacer Sequences: gRNAs
    • 3.7.6 CRISPR Acts on DNA Targets
    • 3.7.7 Cas9 Cleaves Target DNA
    • 3.7.8 tracrRNA for Cas9 Systems
    • 3.7.9 CRISPR Systems in Other Species
    • 3.7.10 Cas9-Mediated Cleavage
    • 3.7.11 CRISPR-Cas9: Genome Editing
  • 3.8 Market Potential
  • 3.9 Regulatory Framework
    • 3.9.1 U.S. Regulation and Oversight
    • 3.9.2 NIH Guidelines
    • 3.9.3 U.S. FDA
    • 3.9.4 Regulatory Issues
    • 3.9.5 Regulations of Human Germline Edits
    • 3.9.6 Global Regulations
  • 3.10 Porter's Five Forces Analysis of the Market for CRISPR Technology
    • 3.10.1 Bargaining Power of Suppliers: Low
    • 3.10.2 Bargaining Power of Buyers: Moderate
    • 3.10.3 The Threat of Substitutes: Moderate
    • 3.10.4 The Threat of New Entrants: Moderate
    • 3.10.5 The Intensity of Competitive Rivalry: Low
  • 3.11 Scientific Publications
  • 3.12 Patent Analysis
    • 3.12.1 Overview of CRISPR Technology Intellectual Property (IP) and Licensing Structure
  • 3.13 Future of CRISPR
  • 3.14 Market Drivers
    • 3.14.1 CRISPR Versus Chronic Disease
    • 3.14.2 High Prevalence of Genetic Disorders
    • 3.14.3 Government and Private Funding
    • 3.14.4 Increasing Applications of CRISPR
  • 3.15 Market Restraints
    • 3.15.1 Alternative Technologies
    • 3.15.2 Off-target Activity
  • 3.16 Market Challenges
    • 3.16.1 Patent Issues
    • 3.16.2 Risks Associated with CRISPR
    • 3.16.3 R&D
    • 3.16.4 Governmental Policies and Regulations
    • 3.16.5 Bioethical Issues

Chapter 4 Industry Structure

  • 4.1 Commercial Therapeutics
  • 4.2 Correcting Genetic Errors
  • 4.3 Microbes
  • 4.4 Healthier Food

Chapter 5 Impact of COVID-19 on the Market for CRISPR Technology

  • 5.1 Overview

Chapter 6 Competitive Landscape

  • 6.1 Overview
  • 6.2 Competitive Scenario
  • 6.3 Beam Therapeutics
  • 6.4 CRISPR Therapeutics
  • 6.5 Editas Medicine
  • 6.6 Intellia Therapeutics
  • 6.7 Growth Strategies
    • 6.7.1 Licensing and Agreements
    • 6.7.2 Collaborations With Big Biopharmaceutical Companies
    • 6.7.3 Mergers and Acquisitions

Chapter 7 Global Market for CRISPR Technology by End User

  • 7.1 Market Overview
  • 7.2 Market Share and Forecast
  • 7.3 Biotechnology and Pharmaceutical Companies
  • 7.4 Academics and Government Research Institutes
  • 7.5 Contract Research Organizations

Chapter 8 Global Market for CRISPR Technology by Application

  • 8.1 Market Share and Forecast
  • 8.2 Drug Development
  • 8.3 Agriculture
  • 8.4 Diagnostics
    • 8.4.1 Infectious Diseases
    • 8.4.2 Non-infectious diseases
  • 8.5 Clinical Therapy
  • 8.6 Others

Chapter 9 Global Market for CRISPR Technology by Region

  • 9.1 North America
    • 9.1.1 U.S.
    • 9.1.2 Canada
  • 9.2 Europe
    • 9.2.1 Germany
    • 9.2.2 United Kingdom
    • 9.2.3 France
    • 9.2.4 Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 Rest of Asia-Pacific
  • 9.4 Rest of the World

Chapter 10 Company Profiles

  • CARIBOU BIOSCIENCES
  • CRISPR THERAPEUTICS AG
  • DANAHER CORP.
  • EDITAS MEDICINE
  • GENSCRIPT
  • HERA BIOLABS
  • INTELLIA THERAPEUTICS INC.
  • LONZA GROUP LTD.
  • MAMMOTH BIOSCIENCES INC.
  • NEW ENGLAND BIOLABS INC.
  • ORIGENE TECHNOLOGIES
  • PERKINELMER
  • PRECISION BIOSCIENCES
  • SYNTHEGO
  • THERMO FISHER SCIENTIFIC
  • TOOLGEN INC.
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제